ACETAMINOPHEN 650MG

ACETAMINOPHEN 650MG was reported 189 times

ACETAMINOPHEN 650MG is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 HYPERACTIVE PHARYNGEAL REFLEX 1 0.0069
1 POST PROCEDURAL BILE LEAK 1 0.0032
2 MENINGISM 1 0.0021
3 GROIN INFECTION 1 0.0018
4 SPINAL EPIDURAL HAEMATOMA 1 0.0017
5 NUCHAL RIGIDITY 1 0.0011
6 HEART TRANSPLANT 1 0.0011
7 MASTOIDITIS 1 0.0010
8 PRODUCT MEASURED POTENCY ISSUE 1 0.0010
9 BLOOD FIBRINOGEN DECREASED 1 0.0009
10 INTERCEPTED PRODUCT SELECTION ERROR 1 0.0008
11 PERIPHERAL ARTERY THROMBOSIS 1 0.0007
12 TRANSCRIPTION MEDICATION ERROR 1 0.0006
13 PHARYNGEAL PARAESTHESIA 1 0.0006
14 INJECTION RELATED REACTION 1 0.0006
15 SEIZURE LIKE PHENOMENA 1 0.0006
16 RECALLED PRODUCT 1 0.0006
17 EAR PRURITUS 2 0.0006
18 CATHETER PLACEMENT 1 0.0005
19 INFUSION RELATED REACTION 32 0.0005
20 BODY TEMPERATURE FLUCTUATION 1 0.0005
21 PRODUCT LOT NUMBER ISSUE 1 0.0005
22 MENINGITIS ASEPTIC 2 0.0004
23 ELECTRIC SHOCK SENSATION 1 0.0004
24 SKIN EROSION 1 0.0003
25 HOSPICE CARE 3 0.0003
26 LIVER TRANSPLANT 1 0.0003
27 FAECES HARD 1 0.0003
28 SPINAL CORD COMPRESSION 1 0.0003
29 EPIGASTRIC DISCOMFORT 1 0.0003
30 PULSELESS ELECTRICAL ACTIVITY 1 0.0002
31 ABSCESS LIMB 1 0.0002
32 TEARFULNESS 1 0.0002
33 BLOOD CREATINE INCREASED 1 0.0002
34 RECALLED PRODUCT ADMINISTERED 2 0.0002
35 TUMOUR MARKER INCREASED 1 0.0002
36 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 1 0.0002
37 GENERALISED ERYTHEMA 1 0.0002
38 ODYNOPHAGIA 1 0.0002
39 PROTHROMBIN TIME PROLONGED 1 0.0002
40 SYMPTOM RECURRENCE 1 0.0002
41 DERMATITIS ACNEIFORM 1 0.0002
42 WHITE BLOOD CELL COUNT ABNORMAL 1 0.0002
43 LIP SWELLING 5 0.0001
44 FORMICATION 1 0.0001
45 THROAT IRRITATION 6 0.0001
46 APNOEA 1 0.0001
47 TORSADE DE POINTES 1 0.0001
48 CYANOSIS 2 0.0001
49 MYASTHENIA GRAVIS 1 0.0001
50 POST PROCEDURAL INFECTION 1 0.0001
51 ESCHERICHIA INFECTION 1 0.0001
52 RESPIRATORY RATE INCREASED 1 0.0001
53 LUPUS-LIKE SYNDROME 1 0.0001
54 PHARYNGEAL SWELLING 1 0.0001
55 THERAPY CHANGE 1 0.0001
56 CYTOKINE RELEASE SYNDROME 2 0.0001
57 THERAPY CESSATION 5 0.0001
58 HYPERBILIRUBINAEMIA 1 0.0001
59 VENTRICULAR FIBRILLATION 1 0.0001
60 MICTURITION URGENCY 1 0.0001
61 OCULAR HYPERAEMIA 4 0.0001
62 MUSCLE SPASTICITY 1 0.0001
63 SMALL INTESTINAL OBSTRUCTION 1 0.0001
64 SECRETION DISCHARGE 1 0.0001
65 BRAIN OEDEMA 1 0.0001
66 HAEMATEMESIS 2 0.0001
67 BEDRIDDEN 1 0.0001
68 ORAL DISCOMFORT 1 0.0001
69 SKIN REACTION 1 0.0001
70 CHEST DISCOMFORT 7 0.0001
71 SKIN DISCOLOURATION 3 0.0001
72 EJECTION FRACTION DECREASED 1 0.0001
73 BASAL CELL CARCINOMA 1 0.0001
74 SWOLLEN TONGUE 2 0.0001
75 PNEUMOTHORAX 1 0.0001
76 PHOTOSENSITIVITY REACTION 1 0.0001
77 GENERALISED TONIC-CLONIC SEIZURE 1 0.0001
78 COAGULOPATHY 1 0.0001
79 CHILLS 7 0.0001
80 FLUID RETENTION 3 0.0001
81 HEART RATE DECREASED 2 0.0001
82 COLD SWEAT 1 0.0001
83 THERAPY INTERRUPTED 4 0.0001
84 RASH PRURITIC 3 0.0001
85 OXYGEN SATURATION DECREASED 3 0.0001
86 BLOOD PRESSURE SYSTOLIC INCREASED 1 0.0001
87 SKIN FISSURES 1 0.0001
88 HAEMATOCRIT DECREASED 1 0.0001
89 PREGNANCY 1 0.0000
90 BLOOD PRESSURE INCREASED 7 0.0000
91 INTERVERTEBRAL DISC PROTRUSION 1 0.0000
92 RASH MACULO-PAPULAR 1 0.0000
93 RASH PAPULAR 1 0.0000
94 CHROMATURIA 1 0.0000
95 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 1 0.0000
96 BURNING SENSATION 3 0.0000
97 DISEASE PROGRESSION 5 0.0000
98 RASH ERYTHEMATOUS 2 0.0000
99 NEURALGIA 1 0.0000
100 UNRESPONSIVE TO STIMULI 1 0.0000
101 RASH GENERALISED 1 0.0000
102 GASTRITIS 1 0.0000
103 ASPARTATE AMINOTRANSFERASE INCREASED 2 0.0000
104 CARDIAC ARREST 3 0.0000
105 RESPIRATORY ARREST 1 0.0000
106 RESPIRATORY DISTRESS 1 0.0000
107 ANAPHYLACTIC REACTION 2 0.0000
108 MENTAL STATUS CHANGES 1 0.0000
109 URTICARIA 6 0.0000
110 DEMENTIA 1 0.0000
111 BLISTER 2 0.0000
112 SKIN EXFOLIATION 3 0.0000
113 ERYTHEMA 7 0.0000
114 HYPOAESTHESIA 5 0.0000
115 BLOOD POTASSIUM DECREASED 1 0.0000
116 LACRIMATION INCREASED 1 0.0000
117 HYPERTENSION 7 0.0000
118 PLEURAL EFFUSION 2 0.0000
119 EPILEPSY 1 0.0000
120 ALANINE AMINOTRANSFERASE INCREASED 2 0.0000
121 PERIPHERAL SWELLING 5 0.0000
122 FEMUR FRACTURE 1 0.0000
123 NERVOUS SYSTEM DISORDER 1 0.0000
124 METABOLIC ACIDOSIS 1 0.0000
125 MOVEMENT DISORDER 1 0.0000
126 SWELLING FACE 2 0.0000
127 STAPHYLOCOCCAL INFECTION 1 0.0000
128 VOMITING 14 0.0000
129 FLUSHING 3 0.0000
130 HAEMATURIA 1 0.0000
131 RASH MACULAR 1 0.0000
132 COUGH 8 0.0000
133 HYPOXIA 1 0.0000
134 RASH 12 0.0000
135 HYPERGLYCAEMIA 1 0.0000
136 DYSURIA 1 0.0000
137 EYE SWELLING 1 0.0000
138 INTESTINAL OBSTRUCTION 1 0.0000
139 HEADACHE 16 0.0000
140 ABORTION SPONTANEOUS 1 0.0000
141 GASTROOESOPHAGEAL REFLUX DISEASE 2 0.0000
142 DYSPNOEA 14 0.0000
143 DRY MOUTH 2 0.0000
144 INFLUENZA LIKE ILLNESS 2 0.0000
145 NAUSEA 19 0.0000
146 ABDOMINAL DISCOMFORT 4 0.0000
147 VAGINAL HAEMORRHAGE 1 0.0000
148 MUSCULOSKELETAL STIFFNESS 2 0.0000
149 ANGIOEDEMA 1 0.0000
150 MUSCLE SPASMS 4 0.0000
151 TINNITUS 1 0.0000
152 SWELLING 2 0.0000
153 NEUROPATHY PERIPHERAL 2 0.0000
154 PYREXIA 7 0.0000
155 DRY EYE 1 0.0000
156 CELLULITIS 1 0.0000
157 HOSPITALISATION 3 0.0000
158 HAEMOGLOBIN DECREASED 2 0.0000
159 PANCREATITIS 1 0.0000
160 BRADYCARDIA 1 0.0000
161 PLATELET COUNT DECREASED 2 0.0000
162 PRURITUS 7 0.0000
163 TREMOR 3 0.0000
164 NECK PAIN 1 0.0000
165 EYE PAIN 1 0.0000
166 EYE IRRITATION 1 0.0000
167 PRODUCT SUBSTITUTION ISSUE 1 0.0000
168 DIARRHOEA 11 0.0000
169 PAIN IN EXTREMITY 5 0.0000
170 FEELING ABNORMAL 4 0.0000
171 STOMATITIS 1 0.0000
172 VERTIGO 1 0.0000
173 FEELING HOT 1 0.0000
174 DEATH 14 0.0000
175 CHEST PAIN 3 0.0000
176 VISUAL IMPAIRMENT 2 0.0000
177 EXPOSURE DURING PREGNANCY 1 0.0000
178 RHINORRHOEA 1 0.0000
179 BLOOD CREATININE INCREASED 1 0.0000
180 FALL 5 0.0000
181 DEHYDRATION 2 0.0000
182 DRY SKIN 2 0.0000
183 HEPATIC ENZYME INCREASED 1 0.0000
184 MULTIPLE SCLEROSIS RELAPSE 1 0.0000
185 ABDOMINAL PAIN UPPER 3 0.0000
186 VISION BLURRED 2 0.0000
187 INJECTION SITE REACTION 1 0.0000
188 RESPIRATORY FAILURE 1 0.0000
189 AGITATION 1 0.0000
190 EPISTAXIS 1 0.0000
191 DIABETES MELLITUS 1 0.0000
192 ACUTE KIDNEY INJURY 2 0.0000
193 BACK PAIN 3 0.0000
194 FATIGUE 10 0.0000
195 PARAESTHESIA 2 0.0000
196 TREATMENT FAILURE 1 0.0000
197 DRUG ABUSE 1 0.0000
198 URINARY TRACT INFECTION 2 0.0000
199 MALAISE 5 0.0000
200 TACHYCARDIA 1 0.0000
201 ADVERSE DRUG REACTION 1 0.0000
202 OROPHARYNGEAL PAIN 1 0.0000
203 DYSPHAGIA 1 0.0000
204 MIGRAINE 1 0.0000
205 CONTUSION 1 0.0000
206 DRUG INTOLERANCE 1 0.0000
207 ATRIAL FIBRILLATION 1 0.0000
208 DYSPEPSIA 1 0.0000
209 SYNCOPE 1 0.0000
210 HYPOTENSION 2 0.0000
211 CONDITION AGGRAVATED 3 0.0000
212 PNEUMONIA 3 0.0000
213 SEPSIS 1 0.0000
214 THROMBOCYTOPENIA 1 0.0000
215 MUSCULAR WEAKNESS 1 0.0000
216 ABDOMINAL PAIN 2 0.0000
217 PALPITATIONS 1 0.0000
218 JOINT SWELLING 1 0.0000
219 EMOTIONAL DISTRESS 1 0.0000
220 OEDEMA PERIPHERAL 1 0.0000
221 LOSS OF CONSCIOUSNESS 1 0.0000
222 HYPERHIDROSIS 1 0.0000
223 PRODUCT QUALITY ISSUE 1 0.0000
224 ANXIETY 2 0.0000
225 INFECTION 1 0.0000
226 PAIN 4 0.0000
227 DRUG INTERACTION 1 0.0000
228 DIZZINESS 3 0.0000
229 CEREBROVASCULAR ACCIDENT 1 0.0000
230 MYALGIA 1 0.0000
231 COVID-19 1 0.0000
232 NASOPHARYNGITIS 1 0.0000
233 HYPERSENSITIVITY 1 0.0000
234 ASTHENIA 2 0.0000
235 OVERDOSE 1 0.0000
236 CONSTIPATION 1 0.0000
237 INCORRECT DOSE ADMINISTERED 1 0.0000
238 DECREASED APPETITE 1 0.0000
239 INSOMNIA 1 0.0000
240 WEIGHT DECREASED 1 0.0000
241 ARTHRALGIA 1 0.0000
242 DRUG INEFFECTIVE 1 0.0000